
Stroke Prevention and Acute Treatment
Jeffrey Saver, MD, May Nour, MD, PhD and Steven C. Cramer, MD
Tuesday, November 7, 2023
5:00 PM - 6:00 PM PT
• Strokes are the leading cause of serious adult disability in the US and the 5th leading cause of death.
• 1 in 6 people will have a stroke in their lifetime
• 800,000 people suffer a stroke each year and 140,000 people die each year from stroke
Join us for an Open Mind presentation on “Stroke Prevention and Acute Treatment” with Jeffrey Saver, MD, Vice-Chair and Professor of Neurology at UCLA and Director of the UCLA Comprehensive Stroke and Vascular Neurology Program.
This Open Mind program will give an overview of types of strokes, available therapies for acute stroke, warning signs, risk factors, lifestyle choices to help prevent stroke, and the mobile stroke rescue program at UCLA.
Joining Dr. Saver in discussion will be:
• Dr. May Nour, Assistant Professor of Neurology and Radiology at
UCLA, and Medical Director of the UCLA Arline and
Henry Gluck Stroke Rescue Program
• Dr. Steven Cramer, Professor of Neurology at UCLA and Director of
Research at California Rehabilitation Institute.
Jeffrey Saver, MD’s research interests are in acute stroke treatment, stroke prevention, neuroimaging, clinical trial design, and neurocognitive consequences of stroke. He has written over 750 research articles, 3 books, and 40 book chapters, served as PI of the NIH-NINDS FAST-MAG trial, Global Co-PI of the SWIFT PRIME trial, and Chair of the American Heart Association Stroke Council. He is currently Associate Editor at JAMA, the Journal of the American Medical Association, and Editorial Board Member at the journal Circulation, and is a recipient of the American Heart Association’s Distinguished Scientist Award, the US Clinical Research Foundation’s Clinical Research Award, and the World Stroke Organization Lifetime Research Award.
May Nour, MD, PhD is dually trained in Vascular Neurology and Endovascular/Interventional Neuroradiology. She received her PhD in neurosciences, focusing on gene therapy for inherited retinal degeneration, from the University of Oklahoma Health Sciences Center. Following her postdoctoral fellowship, she began her medical studies, earning her M.D. degree from the University of Arizona. Dr. Nour continued her neurology and subspecialty training in the medical and minimally invasive surgical/endovascular treatment of neurovascular disease at the University of California, Los Angeles. She is the site Principal Investigator of the federally funded Patient-Centered Outcomes Research Institute demonstration project, assessing the clinical benefit and health care utilization of mobile stroke units for the treatment of ischemic and hemorrhagic diseases of the brain. She is also the site Principal Investigator of the NIH-funded FASTEST trial assessing the efficacy of recombinant factor VIIa for hemorrhagic stroke both in the mobile stroke unit as well as in the emergency department setting. Her research interests are focused on allocation of specialized resources, such as mobile stroke units, in the prehospital setting and improving patient routing to appropriate levels of stroke care.
Steven C. Cramer, MD, is a stroke neurologist whose research focuses on neural repair after central nervous system injury in humans, with an emphasis on stroke and on recovery of movement. Treatments examined include robotics, cellular therapies, a monoclonal antibody, brain stimulation, drugs, and telehealth methods. A major emphasis is on translating new drugs and devices to reduce disability after stroke, and on developing biomarkers to individualize therapy for each person’s needs. Dr. Cramer has received the Stroke Rehabilitation Award from the American Heart Association, the Barbro B. Johansson Award in Stroke Recovery from the World Stroke Organization, the Award for Excellence in Post-Acute Stroke Rehabilitation from the American Congress of Rehabilitation Medicine, and he holds the Susan and David Wilstein Endowed Chair in Rehabilitation Medicine. He also co-edited the book Brain Repair after Stroke and is the author of over 300 manuscripts.